Wolfe Research analyst Mike Polark downgrades Silk Road Medical (NASDAQ:SILK) from Outperform to Peer Perform.
Wolfe Research Downgrades Silk Road Medical to Peer Perform
Wolfe Research analyst Mike Polark downgrades Silk Road Medical (NASDAQ:SILK) from Outperform to Peer Perform.
Related Posts
Goldman Sachs Downgrades eBay to Sell, Lowers Price Target to $42
Goldman Sachs analyst Eric Sheridan downgrades eBay (NASDAQ:EBAY) from Neutral to Sell and lowers the price target from $52 to $42.
The Valens Co. Reaches Third-Largest Cannabis Market In Canada
Cannabis manufacturer The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) revealed Monday it has reached the Québec cannabis market. The Kelowna, British Columbia-based company executed a letter of intent with Société québécois
Mizuho Maintains Buy on Sherwin-Williams, Lowers Price Target to $264
Mizuho analyst Christopher Parkinson maintains Sherwin-Williams (NYSE:SHW) with a Buy and lowers the price target from $288 to $264.